More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.08B
EPS
6.2
P/E ratio
5.7
Price to sales
14.42
Dividend yield
--
Beta
0.284879
Previous close
$36.85
Today's open
$36.40
Day's range
$35.52 - $36.80
52 week range
$33.71 - $60.82
CEO
Anthony Carlson
Employees
4100
Headquarters
Chicago, IL
Exchange
New York Stock Exchange
Shares outstanding
86500000
Issue type
Common Stock
Media & Telecommunications
Telecommunications
Telephone and Data Systems Announces It Is No Longer Pursuing the Acquisition of Public Shares of Array Digital Infrastructure
TDS Expects to Recommence Repurchase Program CHICAGO, Sept. 1, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) (the "Company" or "TDS") today announced that it is no longer pursuing the acquisition of the Common Shares of Array Digital Infrastructure, Inc. (NYSE: AD) ("Array") that it does not already own and has withdrawn its previously announced proposal.
PRNewsWire • Sep 1, 2026

SHAREHOLDER ALERT: Kaskela Law Announces Investigation of Array Digital Infrastructure (NYSE: AD) and Encourages Current Array Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)---- $AD #array--Kaskela Law announces that it is investigating Array Digital Infrastructure, Inc. (NYSE: AD) (“Array”) on behalf of the company's current shareholders. Since August 2025, shares of Array's common stock have declined in value from over $70.00 per share to a current trading price of less than $40.00 per share – a decline of over 42% in value. The investigation seeks to determine whether Array and/or the company's officers and directors violated the securities laws o.
Business Wire • Aug 19, 2026

Array Digital Infrastructure Q2 Earnings Call Highlights
TDS reported second-quarter progress in its fiber expansion and tower infrastructure operations, while updating 2026 guidance for both TDS Telecom and Array Digital Infrastructure NYSE: AD. Management also said it would not provide further updates or take questions regarding TDS's pending proposal to acquire Array shares it does not already own.
MarketBeat • Aug 12, 2026

AD Q2 Earnings Beat Estimates on Strong Site Rental Growth
Array Digital Infrastructure beat Q2 estimates as site rental revenues surge 95%, while spectrum sales boost gains and 2026 guidance.
Zacks Investment Research • Aug 10, 2026

Array reports second quarter 2026 results
Array updates 2026 guidance CHICAGO, Aug. 7, 2026 /PRNewswire/ -- As previously announced, Array will hold a teleconference on August 7, 2026, at 9:00 a.m. CT. Listen to the call live via the Events & Presentations page of investors.arrayinc.com.
PRNewsWire • Aug 7, 2026

Array Digital Infrastructure (AD) Q2 Earnings and Revenues Beat Estimates
Array Digital Infrastructure (AD) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.36 per share a year ago.
Zacks Investment Research • Aug 7, 2026

Zacks Industry Outlook Array Digital, Optimum and AT&T
Array Digital, Optimum and AT&T have been highlighted in this Industry Outlook article.
Zacks Investment Research • Aug 4, 2026

3 Wireless Stocks Set to Overcome Roadblocks on Industry Strength
AD, OPTU and T are likely to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.
Zacks Investment Research • Aug 3, 2026

TDS and Array to release second quarter operating results and host conference call on August 7, 2026
CHICAGO, July 31, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and Array Digital Infrastructure, Inc.(NYSE: AD) will webcast their second quarter operating results conference call on August 7, 2026, at 9:00 a.m. Central Time.
PRNewsWire • Jul 31, 2026

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Officer of Nimbus Therapeutics, to its Board of Directors as the Company advances its TIM 3/4 agonist program through Phase 1b clinical trials in rheumatoid arthritis (RA) and atopic dermatitis (AD). Kazimi brings more than two decades of biotechnology leadership experience spanning company building, corporate strategy, financing, and drug development. As CEO of Nimbus Therapeutics, he has overseen.
Business Wire • Jul 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Array Digital Infrastructure Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.